Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Inactivated types 1, 2, and 3 poliovirus, D antigens · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Group A | EXPERIMENTAL | Will receive fractional doses of IPV Intradermally |
| Group B | ACTIVE_COMPARATOR | Will receive full doses of IPV Intramuscularly |
| Name | Type | Description |
|---|---|---|
| Inactivated types 1, 2, and 3 poliovirus, D antigens | BIOLOGICAL | 0.1 mL, intradermal |
Inclusion Criteria: * Aged 15 to 18 months on the day of inclusion * Informed consent form signed by the parent(s) or other legally acceptable representative * Subjects and parent/guardian able to attend all scheduled visits and comply with all trial procedures * Child having completed all visits o...